Zoetis ZTS Other Non Pharmaceuticals — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zoetis's other non pharmaceuticals — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zoetis's other non pharmaceuticals — revenue?
- Zoetis (ZTS) reported other non pharmaceuticals — revenue of $66M in Q1 2026.
- How has Zoetis's other non pharmaceuticals — revenue changed year-over-year?
- Zoetis's other non pharmaceuticals — revenue decreased by 7.0% year-over-year, from $71M to $66M.
- What is the long-term trend for Zoetis's other non pharmaceuticals — revenue?
- Over 4 years (2021 to 2025), Zoetis's other non pharmaceuticals — revenue has grown at a 3.8% compound annual growth rate (CAGR), from $231M to $268M.
- What does other non pharmaceuticals — revenue mean?
- This metric represents the total revenue generated from the sale of animal health products that fall outside of traditional pharmaceutical categories, such as diagnostics, equipment, or non-drug wellness solutions. It captures the performance of the company's diversified portfolio that supports veterinary practice operations and animal health monitoring. Tracking this revenue stream helps investors understand the company's ability to cross-sell non-drug solutions to its existing veterinary and livestock customer base.